PLATINUM SOCIETY SPONSOR
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
CAFE SPONSOR & NAME BADGE SPONSOR
Otsuka is a global company with an international network of 189 companies, 47,000 employees, 47 affiliated research institutes and 171 manufacturing sites. Otsuka operates in more than 80 countries and regions across Asia-Pacific, America, Europe, and the Middle East. The people at Otsuka are dedicated to creating new products for better health worldwide.
Underpinning these words is our commitment to:
- Creating unique and innovative products
- Improving health and well-being
- Contributing to the lives of people worldwide
ePOSTER LOUNGE SPONSOR
Alexion is focused on providing innovative treatments to patients with life-threatening rare diseases for which there are few, if any, effective treatment options. Alexion established operations in Sydney in 2008 to serve patients in the Australia and Asia region. We aim to work in partnership with all stakeholders including healthcare providers, patient advocacy organisations and government in order to best serve patients. By expanding the knowledge and awareness of rare diseases, we help the medical community improve the process for diagnosis and treatment. Our goal is to bring hope to patients and families by delivering life-changing therapies.
Vifor Pharma Australia specialises in innovative and patient-focused treatments for chronic kidney disease and iron deficiency. We are a leader in the treatment of iron deficiency and iron deficiency anaemia where our products treat over half a million Australia and New Zealand patients annually.
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines and gene therapy for people living with rare diseases such as Fabry, Pompe and other lysosomal storage disorders. Amicus is committed to changing the lives of people with these life-threatening conditions.
Sanofi is dedicated to supporting people through their health challenges.
We are a global biopharmaceutical company focused on human health. We aim to prevent illness with vaccines, provide self-care solutions to better manage personal wellbeing and provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
While our local corporate headquarters are in Sydney we also have offices, state-of-the-art laboratories and a world-class manufacturing facility in Brisbane, and offices across Auckland, Melbourne, Adelaide and Perth.